Summary miR‐155, a microRNA associated with poor prognosis in lymphoma and
leukaemia, has been implicated in the progression of mycosis fungoides (MF), the most …

Cutaneous T-cell lymphoma (CTCL) is a heterogeneous disease group of unknown etiology
with a complex immunological background. As CTCL arises from T cells that have a vital role …

Cutaneous T-cell lymphoma (CTCL) represents a heterogeneous group of potentially
devastating primary skin malignancies. Despite decades of intense research efforts, the …

The applications of disease cluster investigations in medicine have developed rather rapidly
in recent decades. Analyzing the epidemiology of non-random aggregation of patients with a …

Immunostaining of non-adherent cells is commonly performed after adhesion of cells onto
microscope slides either using cytocentrifugation or with the help of charged coating …

Constitutively activated tyrosine kinase JAK3 is implicated in the pathogenesis of cutaneous
T-cell lymphomas (CTCL). The mechanisms of constitutive JAK3 activation are unknown …

While several systemic therapies are approved for cutaneous T cell lymphoma (CTCL), a
non-Hodgkin lymphoma of skin-homing T cells that may involve lymph nodes and peripheral …

Sézary Syndrome (SS) is a rare aggressive epidermotropic cutaneous T-cell lymphoma
(CTCL) defined by erythroderma, pruritis, and a circulating atypical CD4+ T-cell clonal …

Staphylococcus aureus is implicated in disease progression in cutaneous T-cell lymphoma
(CTCL). Here, we demonstrate that malignant T cell lines derived from CTCL patients as well …

Staphylococcus aureus and its toxins have been linked to disease progression and mortality
in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role …